StockData
Maze Therapeutics, Inc. logo

Maze Therapeutics, Inc. (MAZE) stock

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$33.90−0.43 (-1.25%)

Close on Nov 16, 2026Market cap $1.88BP/E –Yield –

Maze Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Maze Therapeutics's EV/EBITDA was 7.0× on Jul 31, 2025.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20257.0×–

More Maze Therapeutics figures

See a number that looks wrong?